Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.

[1]  K. Miller,et al.  Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma. , 1989, Arthritis and rheumatism.

[2]  J. Weissler.  Idiopathic pulmonary fibrosis: cellular and molecular pathogenesis. , 1989, American Journal of the Medical Sciences.

[3]  G. Raghu,et al.  Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. , 1988, The American review of respiratory disease.

[4]  R. A. Bennett,et al.  A homologue of platelet‐derived growth factor produced by rat alveolar macrophages , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  M. Jordana,et al.  Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue. , 1988, The American review of respiratory disease.

[6]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[7]  B. Wallaert,et al.  Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases. , 1988, Thorax.

[8]  R. Crystal,et al.  Pharmacologic suppression of the neutrophil component of the alveolitis in idiopathic pulmonary fibrosis. , 1987, The American review of respiratory disease.

[9]  Gary R. Grotendorst,et al.  Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. , 1987, The New England journal of medicine.

[10]  D. Furst,et al.  Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Prospective study. , 1987, The American journal of medicine.

[11]  J. Dequeker,et al.  D-penicillamine therapy and interstitial lung disease in scleroderma. A long-term followup study. , 1987, Arthritis and rheumatism.

[12]  M. Schwarz,et al.  Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. , 1987, The American review of respiratory disease.

[13]  S. Jimenez,et al.  Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation. , 1987, The American review of respiratory disease.

[14]  M. Turner-Warwick,et al.  The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. , 1987, The American review of respiratory disease.

[15]  Leroy Ec,et al.  A modified scleroderma skin scoring method. , 1986 .

[16]  R. Silver,et al.  Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid. , 1986, Arthritis and rheumatism.

[17]  B. Wallaert,et al.  Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. , 1986, The American review of respiratory disease.

[18]  T. Medsger,et al.  Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis. , 1986, The Journal of laboratory and clinical medicine.

[19]  M. Schwarz,et al.  A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. , 1986, The American review of respiratory disease.

[20]  M. Ramsden,et al.  Lung inflammation in scleroderma: clinical, radiographic, physiologic and cytopathological features. , 1985, The Journal of rheumatology.

[21]  T. Medsger,et al.  The effect of D-penicillamine on pulmonary findings in systemic sclerosis. , 1985, Arthritis and rheumatism.

[22]  V. Ferrans,et al.  Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. , 1985, The American review of respiratory disease.

[23]  M. Hochberg,et al.  Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. , 1984, The American journal of medicine.

[24]  R. Silver,et al.  Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage. , 1984, Arthritis and rheumatism.

[25]  T. The,et al.  Steroid-responsive interstitial pulmonary disease in systemic sclerosis. Monitoring by bronchoalveolar lavage. , 1984, Chest.

[26]  M. Hochberg,et al.  Clinical and Demographic Predictors of Loss of Pulmonary Function in Systemic Sclerosis , 1984, Medicine.

[27]  A. Schutte,et al.  Local immune complexes and inflammatory response in patients with chronic interstitial pulmonary disorders associated with collagen vascular diseases. , 1984, Clinical and experimental immunology.

[28]  O. Braun-falco,et al.  Lung involvement in scleroderma. , 1984, Chest.

[29]  J. Korn.  Fibroblast prostaglandin E2 synthesis. Persistence of an abnormal phenotype after short-term exposure to mononuclear cell products. , 1983, The Journal of clinical investigation.

[30]  M. Hochberg,et al.  Serial pulmonary function in systemic sclerosis. , 1982, The American journal of medicine.

[31]  E. Leroy,et al.  Fibroblast selection in scleroderma , 1982 .

[32]  R. Crystal,et al.  Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Crystal,et al.  Safety of fiberoptic bronchoalveolar lavage in evaluation of interstitial lung disease. , 1981, Chest.

[34]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[35]  A. Salsbury,et al.  Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. , 1980, Thorax.

[36]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[37]  R. Crystal,et al.  Bronchoalveolar Lavage in Interstitial Lung Disease , 1978 .

[38]  W. Roberts,et al.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. , 1977, The Journal of clinical investigation.

[39]  A. Masi,et al.  Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. , 1971, Annals of internal medicine.